According to FDA-approved labeling, the potency and sterility of GLP-1 medications cannot be assured beyond the recommended timeframes
Tirzepatide and Semaglutide are two of the most talked-about medications in the realm of diabetes management and weight control
The gut-brain axis, a bidirectional communication network between the gastrointestinal tract and the central nervous system, integrates these peripheral signals with the central appetite effects to produce comprehensive appetite suppression
However, semaglutide is not currently FDA-approved for treating alcohol use disorder, and research is still limited by small sample sizes, short study durations, and a focus on people with obesity or moderate drinking patterns
Some prescribers and users prefer microdosing schedules (splitting the weekly dose into smaller, more frequent injections), which aren't shown on this standard chart
Combine different protein sources at meals to ensure complete amino acid profiles